Digital health development is taking place in an increasing pace and it can be an answer to many of the challenges in global healthcare. Regulatory framework also needs to evolve to accommodate the new technology development for smooth adaptation of new innovations both in the UK and in Japan.
In this webinar, we invite NICE, NHSX from the UK and MHLW from Japan to discuss opportunities and challenges we face in the digital health. Please join us to discuss how we can work in collaboration to bring innovation in healthcare field.
|9:00 GMT||Opening Remarks Marie-Claire Joyce, Counsellor, Head of Trade, DIT, British Embassy Tokyo|
|9:05||Digital health technology classification and evidence requirements Ms Jeanette Kusel, Director for Scientific Advice, NICE (National Institute for Health and Clinical Excellence）|
|9:20||Foreseeability of reimbursement (applicability, price) (tentative) Dr Indra Joshi, Director of AI, NHSX|
|9:35||DX (Digital Transformation) Action Strategies in Healthcare for SaMD (DASH for SaMD) Mr Yuhei FUKUTA, Deputy Director, Office of Software as a Medical Device Evaluation, Medical Device Evaluation Division, Pharmaceutical Safety and Environmental Health Bureau Ministry of Health Labour and Welfare|
Moderator: Ms Rie FUKAYA, Head, Global Clinical Regulatory Strategy, DG Lab, Digital Garage, Inc.